An antitumor promoter from Moringa oleifera Lam.

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 440, Issue 2, 1999, Pages 181-188

  Guevara, Amelia P ^a   Vargas, Carolyn ^a   Sakurai, Hiromu ^b   Fujiwara, Yasuhiro ^b   Hashimoto, Keiji ^b   Maoka, Takashi ^b   Kozuka, Mutzuo ^c   Ito, Yoshohiro ^c   Tokuda, Harukuni ^d   Nishino, Hoyoku ^d  

^a University of the Philippines Diliman   (Philippines)

^b KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

^c RESEARCH INSTITUTE FOR PRODUCTION DEVELOPMENT   (Japan)

^d KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

Antitumor promoter; Epstein Barr virus early antigen activation; Moringa oleifera Lam.; O ethyl 4 ( L rhamnosyloxy)benzyl carbamate; Two stage carcinogenesis

Indexed keywords

ANTINEOPLASTIC AGENT; DIMETHYLBENZ[A]ANTHRACENE; EARLY ANTIGEN; MORINGA OLEIFERA EXTRACT; NIAZIMICIN; NIAZIRIN; O ETHYL 4 (ALPHA LEVO RHAMNOSYLOXY)BENZYL CARBAMATE; SITOSTEROL DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; DRUG ISOLATION; EPSTEIN BARR VIRUS; FEMALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN CANCER;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANIMALS; ANTIGENS, VIRAL; ANTINEOPLASTIC AGENTS; CARCINOGENICITY TESTS; CARCINOGENS; CELLS, CULTURED; FEMALE; GLYCOSIDES; MICE; MICE, INBRED ICR; PLANT EXTRACTS; SKIN; SPECIFIC PATHOGEN-FREE ORGANISMS; TETRADECANOYLPHORBOL ACETATE;

HUMAN HERPESVIRUS 4; MORINGA OLEIFERA;

EID: 0032922382     PISSN: 13835718     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1383-5718(99)00025-X     Document Type: Article

References (24)

1. E. Quisumbing, Medicinal Plants of the Philippines, Katha Publishing, Phil., 1978, pp. 346-349.
2. H. Gutierrez, Philippine Materia Medica, Vol. 1, National Research Council of the Phil., 1980.
3. Faizi S., Siddiqui B., Saleem R., Saddiqui S., Aftab K. Isolation and structure elucidation of new nitrile and mustard oil glycosides from Moringa oleifera and their effect on blood pressure. J. Nat. Prod. 57:1994;1256-1261.
4. Faizi S., Siddiqui B., Saleem R., Siddiqui S., Aftab K., Gilani A. Fully acetylated carbamate and hypotensive thiocarbamate glycosides from Moringa oleifera. Phytochemistry. 38:1995;957-963. and references cited therein.
5. Faizi S., Siddiqui B., Saleem R., Siddiqui S., Aftab K., Gilani A. Novel hypotensive agents, niazimin A, niazimin B, niazicin A and niazicin B from Moringa oleifera; Isolation of first naturally occurring carbamates. J. Chem Soc., Perkin Trans. I:1994;3035-3640.
6. Eilert U., Wolters B., Nadrtedt A. The antibiotic principle of seeds of Moringa oleifera and Moringa stenopetala. Planta Medica. 42:1981;55-61.
7. Dayrit F., Alcantara A., Villasenor I. The antibiotic compound and its deactivation in aqueous solutions. Phil. J. Sci. 119:1990;23-26.
8. Villasenor I. Bioactive metabolites from Moringa oleifera Lam. Kimika. 10:1994;47-52.
9. Buchnea D. Synthesis of C-18 mixed acid di-acyl-sn-glycerol enantiomers. Lipids. 6:1971;734-739.
10. S. Ghosal, K. Saini, Sitoindosides I and II, Two new anti-ulcerogenic sterylacylglucosides from Musa paradisiaca, J. Chem. Res. (S), 1984, 110.
11. Konoshima T., Matsuda T., Takasaki M., Yamahara J., Kozuka M., Sawada T., Shingu T. Constituents of the bark of Euptelea polyandra. J. Nat. Prod. 48:1985;683.
12. Takasaki M., Konoshima T., Kozuka M., Tokuda H. Antitumor-promoting activities of Euglobals from Eucalyptus plants. Biol. Pharm. Bull. 18:1995;435-438. and references cited therein.
13. Tsushima M., Maoka T., Katsuyama M., Kozuka M., Matsuno T., Tokuda H., Nishino H., Iwashima A. Inhibitory effect of natural carotenoids on Epstein-Barr virus activation activity of a tumor promoter in Raji cells. A screening study for antitumor promoters. Biol. Pharm. Bull. 18(2):1995;227-233. and references cited therein.
14. Takasaki M., Konoshima T., Fujitani K., Yoshida S., Nishimura H., Tokuda H., Nishino H., Iwashima A., Kozuka M. Inhibitors of skin tumor promotion: VIII. Inhibitory effects of euglobals and their related compounds on Epstein-Barr virus activation (I). Chem. Pharm. Bull. 38:1990;2737-2739. and references cited therein.
15. A. Guevara, Isolation and structure elucidation of the antimutagens from Momordica charantia Linn., PhD Dissertation, Univ. of the Phil., 1988.
16. Henle G., Henle W. Immunofluorescence in cells derived from Burkitt's lymphoma. J. Bacteriol. 91:1966;1248-1256.
17. Weeks C.W., Slaga T., Hennings H., Gleason G., Bracken W. Inhibition of phorbol ester-induced tumor promotion in mice by Vitamin A analog and anti-inflammatory steroid. J. Natl. Cancer Inst. 63:1979;401-406.
18. H. Tokuda, H. Ohigashi, K. Koshimizu, Y. Ito, Inhibitory effects of ursolic and oleanolic acid on skin tumor promotion by 12-O-tetradecanoylphorbol-13-acetate, Cancer Letters, 1986, pp. 279-285.
19. K. Mizutani, Biological activities, production, and use of constituents of Licorice, in: C.T. Ho, T. Osawa, M.T. Huang, R.T. Tosen (Eds.), Food Phytochemicals for Cancer Prevention II, Teas, Spices, and Herbs, American Chemical Society, Washington, DC, 1994, pp. 322-328.
20. Guevara A., Sylianco C., Dayrit F., Finch P. Antimutagens from Momordica charantia. Mutat. Res. 230:1990;121-126.
21. A. Guevara, J. Nakar, Isolation and structure elucidation of antimutagens from Leucaena leucocephala. Technical Report, Nat. Sci. Res. Inst., Univ. of the Phil., 1995.
22. O'Brien T.G., Simsiman R.C., Boutwell R.K. Induction of the polyamine biosynthetic enzymes in mouse epidermis by tumor-promoting agents. Cancer Res. 35:1975;1662-1670.
23. Herberman E., Callaham M.F. Induction of terminal differentiation in human promyolocytic leukemia cells by tumor-promoting agents. Proc. Natl. Acad. Sci. U.S.A. 76:1979;1293-1297.
24. Ito T., Kawanishi M., Harayama T., Takabayashi S. Combined effect of the extracts from Croton tiglium, Euphorbia lathyris, Euphorbia tirucalli and n-butyrate on Epstein-Barr virus expression in human lymphoblastoid P3HR-1 and Raji cells. Cancer Letters. 12:1981;175-180.